PIK3CA c.119_120inv ;(p.A40E)

Variant ID: 3-178916732-CT-AG

NM_006218.2(PIK3CA):c.119_120inv;(p.A40E)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Comprehensive analysis of glycoprotein VI-mediated platelet activation signaling pathway for predicting pan-cancer survival and response to anti-PD-1 immunotherapy.

Computational And Structural Biotechnology Journal
Chen, Shuzhao S; Zhang, Limei L; Chen, Lezong L; Huang, Qianqian Q; Wang, Yun Y; Liang, Yang Y
Publication Date: 2023

Variant appearance in text: PIK3CA: A40E
PubMed Link: 37206616
Variant Present in the following documents:
  • mmc9.xlsx, sheet 4
View BVdb publication page



Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Journal For Immunotherapy Of Cancer
Zhu, Shaoming S; Ma, A-Hong AH; Zhu, Zheng Z; Adib, Elio E; Rao, Ting T; Li, Na N; Ni, Kaiyuan K; Chittepu, Veera Chandra Sekhar Reddy VCSR; Prabhala, Rao R; Garisto Risco, Juan J; Kwiatkowski, David D; Mouw, Kent K; Sonpavde, Guru G; Cheng, Fan F; Pan, Chong-Xian CX
Publication Date: 2021-11

Variant appearance in text: PIK3CA: A40E
PubMed Link: 34725212
Variant Present in the following documents:
  • jitc-2021-002917supp002.pdf
View BVdb publication page



AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis.

Plos Genetics
Sánchez-Vázquez, Raúl R; Martínez, Paula P; Blasco, Maria A MA
Publication Date: 2021-03

Variant appearance in text: PI3K: A40E
PubMed Link: 33690611
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural products.

Molecular Oncology
Krushkal, Julia J; Negi, Simarjeet S; Yee, Laura M LM; Evans, Jason R JR; Grkovic, Tanja T; Palmisano, Alida A; Fang, Jianwen J; Sankaran, Hari H; McShane, Lisa M LM; Zhao, Yingdong Y; O'Keefe, Barry R BR
Publication Date: 2021-02

Variant appearance in text: PI3K: A40E
PubMed Link: 33169510
Variant Present in the following documents:
  • Main text
  • MOL2-15-381.pdf
View BVdb publication page



Upregulation of OSBPL3 by HIF1A promotes colorectal cancer progression through activation of RAS signaling pathway.

Cell Death & Disease
Jiao, Hong-Li HL; Weng, Bin-Shu BS; Yan, Shan-Shan SS; Lin, Zi-Mo ZM; Wang, Shu-Yang SY; Chen, Xiao-Ping XP; Liang, Guang-Hua GH; Li, Xiao-Qing XQ; Zhao, Wei-Yi WY; Huang, Jia-Yi JY; Zhang, Dan D; Zhang, Ling-Jie LJ; Han, Fang-Yi FY; Li, Sheng-Nan SN; Chen, Li-Jie LJ; Zhu, Jiong-Hua JH; He, Wen-Feng WF; Ding, Yan-Qing YQ; Ye, Ya-Ping YP
Publication Date: 2020-07-24

Variant appearance in text: PIK3CA: A40E
PubMed Link: 32709922
Variant Present in the following documents:
  • Main text
View BVdb publication page



KRAS regulation by small non-coding RNAs and SNARE proteins.

Nature Communications
Che, Yonglu Y; Siprashvili, Zurab Z; Kovalski, Joanna R JR; Jiang, Tiffany T; Wozniak, Glenn G; Elcavage, Lara L; Khavari, Paul A PA
Publication Date: 2019-11-11

Variant appearance in text: PI3K: A40E
PubMed Link: 31712554
Variant Present in the following documents:
  • Main text
View BVdb publication page



Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.

Biomed Research International
Ma, Yao Y; Feng, Xiao-Fei XF; Yang, Wan-Xia WX; You, Chong-Ge CG
Publication Date: 2019

Variant appearance in text: PIK3CA: A40E
PubMed Link: 31534952
Variant Present in the following documents:
  • BMRI2019-1093815.pdf
View BVdb publication page